Utomilumab
Utomilumab (PF 05082566) is a fully human IgG2 agonist monoclonal antibody that selectively binds to 4-1BB/CD137. Utomilumab can be used in the research of tumors such as follicular and other CD20+ non-Hodgkin lymphomas[1][2][3].
Product Specifications
CAS Number
1417318-27-4
Product Name Alternative
PF 05082566
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/utomilumab.html
Purity
99.90
Solubility
H2O
Smiles
[Utomilumab]
Molecular Weight
(142.78 kDa)
References & Citations
+
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Isoform
TNFRSF9/4-1BB/CD137
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040478-100 1x 100 µL
Mucin 1 / EMA / Episialin / CD227 (E29), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
